About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Molecular Virology
›
top-articles
Molecular Virology
102
(top 1%)
papers
5.1K
(top 1%)
citations
38
(top 1%)
h
-index
71
(top 1%)
g
-index
126
all documents
5.6K
doc citations
891
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Gastroenterology
2014
627
2
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Journal of Hepatology
2016
321
3
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
Journal of Hepatology
2014
217
4
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Nature Genetics
2020
217
5
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
Hepatology
2012
190
6
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Journal of Hepatology
2016
187
7
T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes
Gastroenterology
2008
137
8
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Nature Reviews Gastroenterology and Hepatology
2016
129
9
Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
In Vitro
Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles
Journal of Virology
2018
125
10
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Gut
2021
125
11
NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
International Journal of Molecular Sciences
2014
123
12
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load
Gut
2019
122
13
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism
Hepatology
2014
120
14
Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes
Hepatology
2013
113
15
A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes
Gastroenterology
2012
111
16
MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
PLoS Pathogens
2012
110
17
Apolipoprotein E Likely Contributes to a Maturation Step of Infectious Hepatitis C Virus Particles and Interacts with Viral Envelope Glycoproteins
Journal of Virology
2014
103
18
Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts
Hepatology
2013
102
19
Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
Journal of Hepatology
2018
101
20
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Frontiers in Immunology
2020
100
21
Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications
Journal of Hepatology
2016
98
22
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Journal of Hepatology
2019
90
23
The Pre-S2 Domain of the Hepatitis B Virus Is Dispensable for Infectivity but Serves a Spacer Function for L-Protein-Connected Virus Assembly
Journal of Virology
2010
78
24
Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes
Hepatology
2017
78
25
Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
Molecular Systems Biology
2021
78
26
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles
Journal of Biological Chemistry
2017
76
27
3D Correlative Cryo-Structured Illumination Fluorescence and Soft X-ray Microscopy Elucidates Reovirus Intracellular Release Pathway
Cell
2020
73
28
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Scientific Reports
2017
72
29
The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics
Clinical Pharmacology and Therapeutics
2018
66
30
A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B
European Journal of Pharmaceutics and Biopharmaceutics
2016
63
31
Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor
Journal of Hepatology
2016
63
32
Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors
PLoS ONE
2013
61
33
Inhibitors of Hepatitis B Virus Attachment and Entry
Intervirology
2014
60
34
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Current Opinion in Virology
2018
58
35
Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle
Scientific Reports
2016
56
36
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Journal of Hepatology
2017
47
37
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
EBioMedicine
2016
45
38
Entry of hepatitis B and C viruses — recent progress and future impact
Current Opinion in Virology
2014
43
39
Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes
Methods in Molecular Biology
2017
39
40
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
Nature Communications
2019
39
41
Hepatitis B Virus DNA is a Substrate for the cGAS/STING Pathway but is not Sensed in Infected Hepatocytes
Viruses
2020
39
42
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
Journal of Hepatology
2021
37
43
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Journal of Hepatology
2021
37
44
Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide
Journal of Virology
2016
35
45
T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR
Journal of Virology
2018
35
46
A Spotlight on Viruses—Application of Click Chemistry to Visualize Virus-Cell Interactions
Molecules
2019
34
47
Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
Viruses
2021
34
48
De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
JHEP Reports
2021
33
49
Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells
PLoS Pathogens
2020
26
50
Pharmacologically Triggered Hydrogel for Scheduling Hepatitis B Vaccine Administration
Scientific Reports
2013
25
site/software ©
exaly
; All materials licenced under
CC by-SA
.